Phase II  

A phase II clinical research trial is designed to determine the effectiveness of the drug for a particular indication or indications in patients with the disease or condition that is being studied.  Different doses are usually studied to determine the lowest dose possible that is shown to be effective. The objective of a phase II study is to determine the common side effects and risks associated with the drug on a group of 100 to 300 volunteers.